The DOI matches its Crossref record; 49 of the 49 references it cites were found in a registry or an index.
The Aryl Hydrocarbon Receptor Mediates Degradation of Estrogen Receptor α through Activation of Proteasomes
Open accessAbstract
2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) and other aryl hydrocarbon receptor (AhR) ligands suppress 17beta-estradiol (E)-induced responses in the rodent uterus and mammary tumors and in human breast cancer cells. Treatment of ZR-75, T47D, and MCF-7 human breast cancer cells with TCDD induces proteasome-dependent degradation of endogenous estrogen receptor alpha (ERalpha). The proteasome inhibitors MG132, PSI, and PSII inhibit the proteasome-dependent effects induced by TCDD, whereas the protease inhibitors EST, calpain inhibitor II, and chloroquine do not affect this response. ERalpha levels in the mouse uterus and breast cancer cells were significantly lower after cotreatment with E plus TCDD than after treatment with E or TCDD alone, and our results indicate that AhR-mediated inhibition of E-induced transactivation is mainly due to limiting levels of ERalpha in cells cotreated with E plus TCDD. TCDD alone or in combination with E increases formation of ubiquitinated forms of ERalpha, and both coimmunoprecipitation and mammalian two-hybrid assays demonstrate that TCDD induces interaction of the AhR with ERalpha in the presence or absence of E. In contrast, E does not induce AhR-ERalpha interactions. Thus, inhibitory AhR-ERalpha cross talk is linked to a novel pathway for degradation of ERalpha in which TCDD initially induces formation of a nuclear AhR complex which coordinately recruits ERalpha and the proteasome complex, resulting in degradation of both receptors.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells
Elbashir, S. M., Harborth, J., Lendeckel, W., Yalcin, A., Weber, K., & Tuschl, T. (2001) · Nature · doi:10.1038/35078107 · Cited by 9,456
Hannon, G. J. (2002) · Nature · doi:10.1038/418244a · Cited by 3,538
Mechanisms Underlying Ubiquitination
Pickart, C. M. (2001) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.70.1.503 · Cited by 3,184
Steroid hormone receptors: Many Actors in search of a plot
Beato, M., Herrlich, P., & Schütz, G. (1995) · Cell · doi:10.1016/0092-8674(95)90201-5 · Cited by 1,823
The Multifaceted Mechanisms of Estradiol and Estrogen Receptor Signaling
Hall, J. M., Couse, J. F., & Korach, K. S. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.r100029200 · Cited by 1,208
Identification of essential genes in cultured mammalian cells using small interfering RNAs
Harborth, J., Elbashir, S. M., Bechert, K., Tuschl, T., & Weber, K. (2001) · Journal of Cell Science · doi:10.1242/jcs.114.24.4557 · Cited by 829
Lonard, D. M., Nawaz, Z., Smith, C. L., & O'Malley, B. W. (2000) · Molecular Cell · doi:10.1016/s1097-2765(00)80259-2 · Cited by 562
Katzenellenbogen, J. A. (1996) · Molecular Endocrinology · doi:10.1210/me.10.2.119 · Cited by 535
The Proteasome, a Novel Protease Regulated by Multiple Mechanisms
DeMartino, G. N., & Slaughter, C. A. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.32.22123 · Cited by 530
Ubiquitination: RING for destruction?
Freemont, P. S. (2000) · Current Biology · doi:10.1016/s0960-9822(00)00287-6 · Cited by 522
Lange, C. A., Shen, T., & Horwitz, K. B. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.3.1032 · Cited by 450
Functional Synergy between the Transcription Factor Sp1 and the Estrogen Receptor
Porter, W. W., Saville, B., Hoivik, D. J., & Safe, S. H. (1997) · Molecular Endocrinology · doi:10.1210/me.11.11.1569 · Cited by 428
Self-citationWijayaratne, A. L., & McDonnell, D. P. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m101097200 · Cited by 427
FRAP reveals that mobility of oestrogen receptor-α is ligand- and proteasome-dependent
Stenoien, D. L., Patel, K., Mancini, M. G., Dutertre, M., Smith, C. L., O'Malley, B. W., & Mancini, M. A. (2001) · Nature Cell Biology · doi:10.1038/35050515 · Cited by 393
Zhu, J., Gianni, M., Kopf, E., Honoré, N., Chelbi-Alix, M., Koken, M., Quignon, F., Rochette-Egly, C., & de Thé, H. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.26.14807 · Cited by 372
Davarinos, N. A., & Pollenz, R. S. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.40.28708 · Cited by 306
Ma, Q., & Baldwin, K. T. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.12.8432 · Cited by 302
Alarid, E. T. (1999) · Molecular Endocrinology · doi:10.1210/me.13.9.1522 · Cited by 300
Modes of regulation of ubiquitin-mediated protein degradation
Kornitzer, D., & Ciechanover, A. (2000) · Journal of Cellular Physiology · doi:10.1002/(sici)1097-4652(200001)182:1<1::aid-jcp1>3.0.co;2-v · Cited by 258
Comparative Analyses of Mechanistic Differences Among Antiestrogens1
Wijayaratne, A. L., Nagel, S. C., Paige, L. A., Christensen, D. J., Norris, J. D., Fowlkes, D. M., & McDonnell, D. P. (1999) · Endocrinology · doi:10.1210/endo.140.12.7164 · Cited by 244
Robertson, J. F. R., Nicholson, R. I., Bundred, N. J., Anderson, E., Rayter, Z., Dowsett, M., Fox, J. N., Gee, J. M. W., Webster, A., Wakeling, A. E., et al. (2001) · PubMed · Cited by 216
Krishnan, V., Porter, W., Santostefano, M., Wang, X., & Safe, S. (1995) · Molecular and Cellular Biology · doi:10.1128/mcb.15.12.6710 · Cited by 203
Self-citationDifferential Recruitment of Coactivator RIP140 byAh and Estrogen Receptors
Kumar, M. B., Tarpey, R. W., & Perdew, G. H. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.32.22155 · Cited by 180
Stancovski, I., Gonen, H., Orian, A., Schwartz, A. L., & Ciechanover, A. (1995) · Molecular and Cellular Biology · doi:10.1128/mcb.15.12.7106 · Cited by 169
Nguyen, T. A., Hoivik, D. J., Lee, J., & Safe, S. H. (1999) · Archives of Biochemistry and Biophysics · doi:10.1006/abbi.1999.1282 · Cited by 168
Self-citationJain, S., Dolwick, K. M., Schmidt, J. V., & Bradfield, C. A. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)31725-3 · Cited by 164 · cited 1×
“The high basal activity of pmAhR in ZR-75 cells is in contrast to the lower response observed for pmAhR (mouse) in COS cells, which was similar to the activity of pm alone (19).”
ResultCooperative Interaction between AhR·Arnt and Sp1 for the Drug-inducible Expression of CYP1A1 Gene
Kobayashi, A., Sogawa, K., & Fujii-Kuriyama, Y. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.21.12310 · Cited by 162
Hormone binding induces rapid proteasome-mediated degradation of thyroid hormone receptors
Dace, A., Zhao, L., Park, K. S., Furuno, T., Takamura, N., Nakanishi, M., West, B. L., Hanover, J. A., & Cheng, S.-Y. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.160257997 · Cited by 158
Roberts, B. J., & Whitelaw, M. L. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.51.36351 · Cited by 156
Kopf, E., Plassat, J.-L., Vivat, V., de Thé, H., Chambon, P., & Rochette-Egly, C. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m002840200 · Cited by 155 · cited 2×
“In contrast, synthetic or endogenous ligands for the progesterone receptor, thyroid hormone receptor, retinoic acid receptor (RAR), and ER activate proteasome-dependent receptor degradation (4, 6, 23 , 27, 28, 45, 46, 55).”
BackgroundGillesby, B. E., Stanostefano, M., Porter, W. W., Safe, S. H., Wu, Z.-F., & Zacharewski, T. R. (1997) · Biochemistry · doi:10.1021/bi962131b · Cited by 152
Self-citationReiners, J. J., Lee, J., Clift, R. E., Dudley, D. T., & Myrand, S. P. (1998) · Molecular Pharmacology · doi:10.1124/mol.53.3.438 · Cited by 148
Implication of proteasome in estrogen receptor degradation
Khissiin, A. E., & Leclercq, G. (1999) · FEBS Letters · doi:10.1016/s0014-5793(99)00343-9 · Cited by 139
Wormke, M., Stoner, M. A., Saville, B., & Safe, S. H. (2000) · FEBS Letters · doi:10.1016/s0014-5793(00)01830-5 · Cited by 139
Self-citationDegradation of c-Fos by the 26S Proteasome Is Accelerated by c-Jun and Multiple Protein Kinases
Tsurumi, C., Ishida, N., Tamura, T., Kakizuka, A., Nishida, E., Okumura, E., Kishimoto, T., Inagaki, M., Okazaki, K., Sagata, N., et al. (1995) · Molecular and Cellular Biology · doi:10.1128/mcb.15.10.5682 · Cited by 139
Romkes, M., & Safe, S. (1988) · Toxicology and Applied Pharmacology · doi:10.1016/0041-008x(88)90177-9 · Cited by 137
Self-citationKlinge, C. M., Kaur, K., & Swanson, H. I. (2000) · Archives of Biochemistry and Biophysics · doi:10.1006/abbi.1999.1552 · Cited by 123
Abdelrahim, M., Samudio, I. J., Smith, R., Burghardt, R. C., & Safe, S. H. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m203828200 · Cited by 117
Self-citationLi, X.-Y., Boudjelal, M., Xiao, J. H., Peng, Z.-H., Asuru, A., Kang, S., Fisher, G. J., & Voorhees, J. J. (1999) · Molecular Endocrinology · doi:10.1210/mend.13.10.0362 · Cited by 117
Inhibiting Proteasomes in Human HepG2 and LNCaP Cells Increases Endogenous Androgen Receptor Levels
Sheflin, L. G., Keegan, B. P., Zhang, W., & Spaulding, S. W. (2000) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2000.3424 · Cited by 114
Duan, R., Porter, W. W., Samudio, I. J., Vyhlidal, C. A., Kladde, M. P., & Safe, S. H. (1999) · Molecular Endocrinology · doi:10.1210/mend.13.9.0338 · Cited by 113
Self-citationRowlands, J. C., McEwan, I. J., & Gustafsson, J.-Α. (1996) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)09308-3 · Cited by 111
Boudjelal, M., Wang, Z., Voorhees, J. J., & Fisher, G. J. (2000) · PubMed · Cited by 98
Physiological implications of estrogen receptor modulation by 2,3,7,8-tetrachlorodibenzo-p-dioxin
Umbreit, T. H., & Gallo, M. A. (1988) · Toxicology Letters · doi:10.1016/0378-4274(88)90097-5 · Cited by 76
Aromatase inhibitors ? mechanisms of steroidal inhibitors
Brueggemeier, R. W. (1994) · Breast Cancer Research and Treatment · doi:10.1007/bf00682739 · Cited by 75
Porter, W. W., Wang, F., Duan, R., Qin, C., Castro‐Rivera, E., Kim, K., & Safe, S. H. (2001) · Journal of Molecular Endocrinology · doi:10.1677/jme.0.0260031 · Cited by 68
Self-citationPollenz, R. S., & Barbour, E. (2000) · Molecular and Cellular Biology · doi:10.1128/mcb.20.16.6095-6104.2000 · Cited by 65
McDougal, A. J., Wormke, M., Calvin, J. A., & Safe, S. H. (2001) · PubMed · Cited by 64
Self-citationSantiso‐Mere, D., Sone, T., Hilliard, G. M., et al. (1993) · Molecular Endocrinology · doi:10.1210/mend.7.7.8413308 · Cited by 58
Cited by
Aryl hydrocarbon receptor ligands in cancer: friend and foe
Murray, I. A., Patterson, A. D., & Perdew, G. H. (2014) · Nature Reviews Cancer · doi:10.1038/nrc3846 · Cited by 883
The Aryl Hydrocarbon Receptor Complex and the Control of Gene Expression
Beischlag, T. V., Morales, J. L., Hollingshead, B. D., & Perdew, G. H. (2008) · Critical Reviews™ in Eukaryotic Gene Expression · doi:10.1615/critreveukargeneexpr.v18.i3.20 · Cited by 727
“This suggests that TCDD induces the expression of another inhibitory factor of E2-mediated gene induction, such as activation of proteasomes leading to increased ER degradation.(15) A direct transcriptional mechanism for TCDD-induced repression of E2 signaling was proposed with the identification of an inhibitory DRE…”
BackgroundBonefeld-Jørgensen, E. C., Long, M., Hofmeister, M. V., & Vinggaard, A. M. (2007) · Environmental Health Perspectives · doi:10.1289/ehp.9368 · Cited by 502
Frye, C., Bo, E., Calamandrei, G., Calzà, L., Dessì‐Fulgheri, F., Fernández, M., Fusani, L., Kah, O., Kajta, M., Le Page, Y., et al. (2012) · Journal of Neuroendocrinology · doi:10.1111/j.1365-2826.2011.02229.x · Cited by 431
Pascussi, J.-M., Gerbal-Chaloin, S., Duret, C., Daujat-Chavanieu, M., Vilarem, M.-J., & Maurel, P. (2008) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.47.120505.105349 · Cited by 298
Metadata
- Authors
- Wormke, M., Stoner, M., Saville, B., Walker, K., Abdelrahim, M., Burghardt, R., & Safe, S.
- Venue
- Molecular and Cellular Biology
- Publisher
- Informa UK Limited
- Published
- 2003-03-01
- Volume
- 23
- Issue
- 6
- Pages
- 1843-1855
- ISSN
- 0270-7306 (ISSN-L)
- 1098-5549
- OpenAlex
- W2125077061
- Cited by
- 325
- References
- 49
- FWCI
- 11.72
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.